Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$823K Buy
3,870
+1,113
+40% +$256K 0.31% 86
2021
Q2
$672K Buy
2,757
+13
+0.5% +$3.2K 0.25% 91
2021
Q1
$683K Sell
2,744
-41
-1% -$9.78K 0.21% 115
2020
Q4
$640K Buy
2,785
+12
+0.4% +$2.77K 0.21% 115
2020
Q3
$705K Sell
2,773
-119
-4% -$29.5K 0.28% 93
2020
Q2
$682K Buy
2,892
+12
+0.4% +$2.74K 0.31% 88
2020
Q1
$584K Sell
2,880
-320
-10% -$69.9K 0.32% 88
2019
Q4
$771K Sell
3,200
-98
-3% -$21.6K 0.31% 85
2019
Q3
$638K Sell
3,298
-306
-8% -$58.7K 0.28% 98
2019
Q2
$664K Sell
3,604
-9
-0.2% -$1.61K 0.29% 90
2019
Q1
$686K Buy
3,613
+104
+3% +$19.9K 0.31% 88
2018
Q4
$683K Sell
3,509
-102
-3% -$19.9K 0.35% 78
2018
Q3
$749K Buy
3,611
+125
+4% +$24.6K 0.34% 83
2018
Q2
$643K Buy
3,486
+14
+0.4% +$2.48K 0.3% 92
2018
Q1
$592K Buy
3,472
+14
+0.4% +$2.57K 0.29% 95
2017
Q4
$601K Buy
3,458
+123
+4% +$21.8K 0.28% 96
2017
Q3
$621K Sell
3,335
-288
-8% -$51K 0.36% 81
2017
Q2
$623 Sell
3,623
-58
-2% -$9.43K 0.32% 70
2017
Q1
$604K Buy
+3,681
New +$612K 0.31% 88
2015
Q2
$583K Buy
+3,799
New +$609K 0.37% 70
2014
Q4
$2.37M Buy
14,852
+97
+0.7% +$15.1K 0.82% 40
2014
Q3
$2.07M Buy
14,755
+294
+2% +$38.4K 0.76% 44
2014
Q2
$1.71M Buy
14,461
+329
+2% +$38.1K 0.63% 62
2014
Q1
$1.74M Buy
14,132
+724
+5% +$87.8K 0.68% 55
2013
Q4
$1.53M Sell
13,408
-82
-0.6% -$9.33K 0.63% 62
2013
Q3
$1.51M Sell
13,490
-262
-2% -$28.4K 0.6% 58
2013
Q2
$1.36M Buy
+13,752
New +$1.43M 0.57% 60

Other funds holding AMGN

FMA Advisory's AMGN Position: Q3 2021 in Review

FMA Advisory increased its Amgen (AMGN) stake by 40% in Q3 2021, buying an estimated $256K and bringing the position to 3,870 shares worth $823K. The position accounts for 0.31% of the portfolio, ranked #86.

FMA Advisory first reported a position in AMGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.37M in Q4 2014. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • FMA Advisory held 3,870 shares of Amgen worth $823K as of Q3 2021.
  • FMA Advisory bought 1,113 Amgen shares in Q3 2021, an estimated $256K.
  • Amgen made up 0.31% of FMA Advisory's portfolio in Q3 2021, its #86 holding.
  • FMA Advisory first reported a position in Amgen in Q2 2013 and has held it in 27 quarters since.
  • FMA Advisory's Amgen position peaked at $2.37M in Q4 2014.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.